FDA Inspection 700534 — H & P Industries, Inc.

H & P Industries, Inc. — FEI 2128643

The FDA completed an inspection of H & P Industries, Inc. on January 7, 2011 in Hartland, WI. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 44 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
January 7, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Hartland, WI (United States)

Citations

IDCFRDescription
104921 CFR 211.22(a)Approve or reject components, products
110521 CFR 211.22(d)Procedures not in writing, fully followed
111121 CFR 211.25(a)Training , Education , Experience overall
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
113421 CFR 211.25(b)Supervisor Training/Education/Experience
113621 CFR 211.25(c)Inadequate number of personnel
117721 CFR 211.63Equipment Design, Size and Location
121321 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
135821 CFR 211.100(b)SOPs not followed / documented
139521 CFR 211.103Actual vs. theoretical yields not determined
141121 CFR 211.105(b)Distinctive ID or code not recorded in batch record
145021 CFR 211.113(a)Procedures for non-sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
163221 CFR 211.130(c)Lot or control number assigned
176721 CFR 211.137(a)Expiration date lacking
177421 CFR 211.142(a)Quarantine - actual practice
180921 CFR 211.160(a)Following/documenting laboratory controls
188321 CFR 211.165(a)Testing and release for distribution
188521 CFR 211.165(b)Microbiological testing
189121 CFR 211.165(f)Failing drug products not rejected
191221 CFR 211.166(a)Written program not followed
193221 CFR 211.167(a)Sterility/pyrogen-free testing
200721 CFR 211.186(a)Signature and checking of records -- 2 persons
202721 CFR 211.192Investigations of discrepancies, failures
202821 CFR 211.192Extent of discrepancy, failure investigations
310821 CFR 820.70(e)Contamination control, Lack of or inadequate procedures
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
312521 CFR 820.80(d)Lack of or inadequate final acceptance procedures
313021 CFR 820.100(a)Lack of or inadequate procedures
355321 CFR 211.48(a)Plumbing System Defects
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified
358521 CFR 211.110(a)Control procedures to monitor and validate performance
360221 CFR 211.160(a)Deviations from laboratory control requirements
360321 CFR 211.160(b)Scientifically sound laboratory controls
431421 CFR 211.84(d)(2)Reports of Analysis (Components)
432421 CFR 211.110(b)In-process materials specifications testing
432521 CFR 211.110(a)Control procedures fail to include the following
434021 CFR 211.142Written warehousing procedures established/followed
435721 CFR 211.166(a)Results not used for expiration dates, storage cond.
439121 CFR 211.180(e)(2)Items to cover on annual reviews
440221 CFR 211.192Written record of investigation incomplete
440421 CFR 211.194(a)(1)Sample identification and other information
47921 CFR 820.50Purchasing controls, Lack of or inadequate procedures
54621 CFR 820.75(a)Lack of or inadequate process validation